Hyperinsulinemia (HI) Competitive Landscape 2024
11 avr. 2024 11h40 HE
|
Research and Markets
Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Hyperinsulinemia (HI) - Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.This reports provides a data-driven...
Dipeptidyl Peptidase IV (DPP-4) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast - 2034
13 mars 2024 14h11 HE
|
Research and Markets
Dublin, March 13, 2024 (GLOBE NEWSWIRE) -- The "Dipeptidyl Peptidase IV (DPP-4) Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast - 2034" report has been added...
Glucagon-like Peptide-1 (GLP-1) Agonists for 7MM: Market Size, Target Population, Competitive Landscape & Forecasts, 2020-2023 and 2024-2034
04 mars 2024 11h24 HE
|
Research and Markets
Dublin, March 04, 2024 (GLOBE NEWSWIRE) -- The "Glucagon-like Peptide-1 (GLP-1) Agonists Market Size, Target Population, Competitive Landscape & Market Forecast - 2034" report has been added to ...
JARDIANCE (Empagliflozin) Market Forecast Reveals Major Role in Myocardial Infarction Treatment and Competitive Landscape Analysis Through 2032
28 févr. 2024 11h09 HE
|
Research and Markets
Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The "JARDIANCE Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering. A comprehensive market...
Global Glucagon-Like Peptide 1 (GLP-1) Agonist (Tirzepatide, Semaglutide, Dulaglutide, Others) Market Research Report 2024
26 févr. 2024 11h24 HE
|
Research and Markets
Dublin, Feb. 26, 2024 (GLOBE NEWSWIRE) -- The "Global Glucagon-Like Peptide 1 (GLP-1) Agonist market (2024 Edition): Analysis by Type, End-Use (Type 2 Diabetes, NASH, Obesity), By Distribution...
North America Sulfonylureas Market Projected to Grow, Hitting USD 3.35 Billion Valuation by 2028 with Notable CAGR of 1.90%
30 janv. 2024 20h00 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "North America Sulfonylureas Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)" report has been added to ...
China Diabetes Care Drugs Market to Reach USD 13.73 Billion by 2028, Propelled by Rising Prevalence and Advanced Treatment Options
30 janv. 2024 19h57 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "China Diabetes Care Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)" report has been added to ...
RYZODEG Drug & Market Forecast Report 2023-2032: Reveals Comprehensive Insights for Type 1 Diabetes Mellitus Treatment - Mechanism of Action, Clinical Assessments, Market Dynamics, Emerging Competitors
30 janv. 2024 06h58 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "RYZODEG Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Offering an in-depth analysis of the...
Cell Therapies for Type 1 Diabetes: 2023-2030 Industry Outlook Featuring Analysis of Leading Players Novo Nordisk, Sanofi, Vertex Pharmaceuticals, Sernova, and Throne Biotechnologies
30 janv. 2024 04h49 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Cell Therapies for Type 1 Diabetes (2023 Edition): Global and Country Analysis By Epidemiology, Pipeline and Target Market Assessment" report has been...
PRV-031 (teplizumab) Drug Insight and Market Forecast to 2032: Highlights Opportunities Across Key Regions
29 janv. 2024 12h21 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "PRV-031 Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report reveals extensive insights...